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Electrospray ionization mass spectrometry was used to characterize several different neu- 
ropeptides, whose molecular weights ranged from 555 to 3463 Da, and to quantify endoge- 
nous methionine enkephalin (ME) and /3-endorphin (PE) extracted from a human pituitary 
gland. Methionine enkephalm and leucine enkephalin both yield only an [M + H]+ ion 
with electrospray mass spectrometry; the other peptides produce a series of multiply 
charged even-electron molecular ions of the general nature [M + nHln+ in proportion to 
the number of basic amino acid units present, with no evidence of fragmentation. The 
electrospray mass spectra are characterized by low background noise. The quantihcation of 
ME is based on a comparison of the ion current due to the [M + H]+ ion of native and of a 
deuterated ME ([2Hs- Phe]-ME) internal standard. The calibration curve is linear in the 
range of ca. l-35 pmol synthetic ME. The amounts of ME determined in three separate 
human pituitary extracts were 9.1, 8.2, and 4.7 pmol/mg protein. The corresponding 
ituitary was 39.8 pmol/mg protein. To quantify /3E, the ion 
ion was monitored and compared to an external calibration 
curve obtained by analyzing solutions of synthetic PE in the range 5 fmol-50 pmol. The 
analysis of a human pituitary yielded 660 fmol @E/mg protein. (J Am Sot Muss Specfrom 
1991, 2, 149-156) 
T he focus of current interest in mass spectrome- try is to develop ionization methods appropriate for the analysis of biomolecules of ever-increas- 
ing molecular size. In the past, the use of mass spec- 
trometry in this field was hampered because these 
polar, nonvolatile, and thermally labile molecules were 
not readily accessible to conventional ionization meth- 
ods. Several so-called soft ionization techniques are in 
current use to produce intact molecular ions from 
complex and fragile biomolecular species. Underiva- 
tized peptides, proteins, oligonucleotides, carbohy- 
drates, and lipids are being analyzed routinely by fast 
atom bombardment (FAB) [I], secondary ion mass 
spectrometry [Z], held desorption [3], laser desorption 
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[41# 252Cf-plasma desorption [5], and thermospray [6] 
mass spectrometry. 
Recent developments in sample introduction and 
ionization techniques include electrospray [7-91 and 
its variation, ion-spray [lo, 111. The origin of electro- 
spray can be traced back to early pioneering experi- 
ments of Dole [12, 131. These techniques are capable 
of producing a series of multiply charged molecular 
ions, of the general nature [M + nH]“+, from complex 
and fragile biomolecules, and no evidence of fragmen- 
tation. The benefits of multiple-charging are to extend 
significantly the usable mass range of a mass spec- 
trometer in proportion to the number of charges on 
the analyte, and to permit determination of the molec- 
ular weight (M,) of large biomolecules [ll, 14, 151. 
For example, the electrospray spectrum of the bovine 
albumin dhner [M, = 133,000 Da] was found to con- 
tain ions with over 120 charges [14, 161. 
Received April 19,199O 
Accepted September 19, 1990 
150 DASS ET AL. J Am Sot Mass Spectrom 1991, 2, 149-156 
Table 1. Neuropeptides investigated by using elechospray mass SpeCtimeq 
Neuropeptide M, Amino acid sequence 
Leucine enkephalin (LE) 555.3 YGGFL 
Methionine enkephalin IME) 
ME-Lys-Lys 
Dynorphin A,_* 
Dynorphin A1.9 
Dynorphin A,.,o 
Dynarphin A 1_1J 
Dynorphin A ,~,, 
Dynorphin 91.,5 
fl-Endorphin,.J1 
573.2 YGGFM 
829.4 YGGFMKK 
980.6 YGGFLRRI 
1136.7 YGGFLRRIR 
1233.7 YGGFLRRIRP 
1603.0 YGGFLRRIRPKLK 
2146.2 YGGFLRRIRPKLKWNNQ 
1569.9 YGGFLRRQFKVVT 
3462.6 YGGFMTSEKSQTPLVTLFKNAIIKNAYKKGE 
In principle, electrospray is an electric field-as- 
sisted phenomenon. A solution of the analyte is 
passed through a metal capillary. A difference in 
potential of several kilovolts between the capillary 
and the surrounding chamber charges the surface of 
the emerging liquid droplets. Coulombic explosion of 
these evaporating liquid droplets promotes dispersion 
of the liquid into a fine spray of charged droplets. As 
this process continues, a concomitant increase in sur- 
face charge density produces strong electric helds that 
facilitate desbrption of solute ions. 
In this article, we report the use of electrospray to 
obtain mass spectra of the opioid peptides listed in 
Table 1. We have also developed methods to quantify 
endogenous methionine enkephalin (ME) and @-en- 
dorphin (PE) from human pituitary extracts. The 
quantification of ME is based on a comparison of the 
ion currents due to the [M + H]+ ions of ME and 
[2H,-4Phe]-ME. To quantify PE, the ion current due 
to the [M + 5H15+ ion was monitored and compared 
to an external call%ration curve. 
An off-line combination of high-performance liquid 
chromatography combined with mass spectrometry 
(HPLC/MS) was used in the present study. Although 
on-line HPLC/MS in some cases may be superior to 
off-line HPLC/MS, high liquid flow rates of HPLC 
have long been a constant source of concern in cou- 
pling HPLC with mass spectrometry. The atmo- 
spheric pressure ionization (API) electrospray and 
API-ionspray ion sources can handle effectively the 
liquid flow rates encountered in microbore-packed 
(5-10 pL/min) and conventional l-mm i.d. (40-50 
PL/min) HPLC columns, respectively [17]. The poten- 
tial of HPLC/API-ionspray for the analysis of small 
dynorphin-related peptides [18, 191 and protein di- 
gests [20] was demonstrated recently. On the other 
hand, off-line HPLC/MS enjoys the advantage that 
mass spectrometric analysis of collected fractions is 
not limited to any specific ionization method. For over 
a decade, our research on the analysis of endogenous 
neuropeptides from biological samples has relied suc- 
cessfully on the off-line HPLC/MS combination [21]. 
Therefore, for evaluation of this new mode of ioniza- 
tion, it was appropriate to use similar sample-han- 
dling conditions. 
The motivation for the present investigation is the 
fact that the intensity of the molecular ion signal in 
the more extensively used FAB/h4S method is depen- 
dent on the relative hydrophobicity/hydrophilicity of 
various chemical constituents (analyte, matrix, impu- 
rities, etc.) present on the FAB probe tip [22]. Hy- 
drophobic peptides preferentially occupy the surface 
of the FAB matrix and thus are ionized more readily. 
Because of this phenomenon and because of the mul- 
ticomponent nature of a biological extract, many of 
the endogenous neuropeptides in tissue extracts are 
often difficult to ionize by using FAB, especially when 
present in low amounts (picomole and less). Further- 
more, chemical noise produced by the FAB matrix [23] 
and other biological compounds present in the tissue 
extract begins to interfere at the picomole level. 
The peptides studied here are important because 
they play crucial roles in various biochemical and 
neurochemical processes 1241. Their concentration in 
body fluids and tissues has been correlated with vari- 
ous psychiatric and metabolic disorders [25]. It is 
crucial to gain an understanding of the mass spectro- 
metric behavior of these endogenous peptides before 
their concentration can be monitored accurately in 
body tissues and fluids. 
Most laboratories use non-mass spectrometry 
methods, such as radioreceptorassay or radioim- 
munoassay, either alone or in combination with HPLC 
to analyze endogenous peptides [26]. Although those 
methods possess high detection sensitivity (picomole 
to fentomole, respectively), the claim of their high 
molecular specihcity cannot be supported. Those as- 
says exhibit varying degrees of cross-reactivities be- 
cause they are based only on a receptor-binding or an 
antigen-antibody reaction, both of which cannot be 
highly specific to an amino acid sequence of a pep- 
tide. The greater complexity of several different, en- 
dogenous, structurally closely related neuropeptides 
that belong to the three opioid families demands the 
use of unambiguous sequence-specific analytical 
methods for identihcation and quantification of those 
peptides. 
Experimental 
Materials. All synthetic peptides studied here were 
purchased from Sigma Chemical Co. (St. Louis, MO), 
and were used without further purification. [2H5]- 
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Phenylalanine from Merck (St. Louis, MO), 
from Fluka Chemical Corp. 
(Ronkonkoma, NY). 
[‘Hs- 
‘Phe]-ME, used syn- 
thesized using the solid-phase peptide synthesis 
(SPPS) procedure on an Applied Biosystems (Foster 
CA) Model 430A [27]. The 
t-butoxycarbonyl derivative of [‘Hs]-phenylalanine 
[28]. After completion of the SPPS, 
resin was treated with acid (by lmmuno- 
dynamics, San Diego, CA) to deblock 
from the resin. The crude [2H,-4Phe]-ME 
was purified 
Three human pituitaries were 
topsy and stored at -70°C until processed 
under National Institutes of Health guidelines 
tive Medicine. 
Tissue extracfion and purification. The procedure used 
here for tissue extraction and purification was de- 
scribed in detail elsewhere 1271. In brief, the pituitary 
tissue was homogenized in cold (4°C) 1 N acetic acid 
in a Polytron (Brinkman, Westbury, NY; setting = 6). 
After equilibration at 4°C for 2 h, the homogenate 
was centrifuged (131,000 x g, 30 min). The super- 
natant was applied to an octadecylsilyl (ODS) RP-Sep- 
Pak disposable cartridge (Waters Associates, Milford, 
MA), and eluted with a 50: 50 (v: v) acetonitrile 
(CH,CN) : 0.1% trifluoroacetic acid solvent mixture to 
prepare a sample enriched in oligopeptides. 
The peptide-rich fraction was separated into indi- 
vidua1 fractions with a gradient ODS RIP-HPLC. Tn- 
ethylamine formate (TEAF; 40 mM; pH 3.1) was used 
as the volatile buffer and CHaCN as the organic 
modifier [29]. Ninety fractions were collected at 1-min 
intervals. For example, synthetic ME and BE eluted at 
24 and 73 mm, respectively. The ME fraction was 
purified further by an additional chromatography step 
by using isocratic RP-HPLC, which employed a syn- 
thetic polymer (polystyrene-polydivinylbenzene; 
Polymer Laboratories, Amherst, MA) column [27] and 
a 16 : 84 (v : v) CHsCN : TEAF solvent mixture as an 
eluent. 
Mass specfmmefry. All experiments were conducted 
on a prototype VG BioQ mass spectrometer operating 
in the positive ion mode and at unit mass resolution. 
The instrument is a single quadrupole mass analyzer 
with a mass range for singly charged ions of ca. 3000 
u, and was outhtted with an API-electrospray ion 
source and a minicomputer-based VG H-250 M + 
data system. The spectra were obtained by scanning 
the instrument from 10-2000 u in 10 s. The mass scale 
was calibrated with a separate introduction of myo- 
globin (average M, = 16,950.5 Da), which gives a se- 
ries of multiply charged molecular ion peaks in the 
required mass range. 
The neuropeptides were dissolved in a 50 : 50 (v : v) 
methanol : water solvent containing 1% acetic acid to 
provide a concentration of ca. 30 pmol/pL. An aliquot 
(10 pL) of this solution was injected into a continuous 
flow (4 pL/min) of the same solvent entering the ion 
source. 
To analyze endogenous ME, each pituitary extract 
lyophilizate was dissolved in 50 ,uL of the electrospray 
solvent, and 10 pL was introduced into the ion source 
as discussed above. The instrument was scanned over 
the narrow mass range 570-584 u to collect the ion 
current due to the [M + H]+ ions of ME and [‘Hs- 
4Phe]-ME. A total of 20 scans was accumulated within 
ca. 75 s by operating the data system in the multi- 
channel analyzer mode. Approximately 5 FL of the 
sample (equivalent to 10% of the original sample) was 
consumed during the analysis. 
Endogenous PE from the human pituitary extract 
was analyzed in a similar fashion by scanning the 
mass spectrometer across the mass range 685-705 u to 
collect the ion current due to the [M + 5H15+ ion at 
m/z 694, which is the most dominant ion in the 
electrospray mass spectrum of @E. The lyophilized 
HF’LC fraction was dissolved in 500 PL of the electro- 
spray solvent, and was analyzed for PE by electro- 
spraying 10 PL (equivalent to 2% of the original tis- 
sue) of that solution. 
Results and Discussion 
Eiectrospray Mass Spectra 
Many of the peptides listed in Table 1 were previously 
characterized by FAB/MS [30-331. Except for ME and 
leucine enkephalin (LE), all peptides contain basic 
ammo acid residues. Electrospray has been shown to 
produce intact multiply charged molecular ion species 
[7-11, 14-161. It is of interest to determine how these 
biologically important peptides behave when sub- 
jected to electrospray. That knowledge is helpful in 
their identification and quantiftcation from extracts of 
body tissues and fluids. Table 2 lists the relative 
abundance of the different protonated molecular ions 
observed in the electrospray mass spectra of these 
neuropeptides. As representative examples, the mass 
spectra of LE (M, = 555 Da) and /3E (M, = 3463 Da) 
are illustrated in Figures 1 and 2, respectively. Ap- 
proximately 7% (equivalent to 20 pmol) of the total 
amount (= 300 pmol) of each peptide injected into the 
ion source was consumed in obtaining these single- 
scan spectra. Unliie FAB mass spectra, the electro- 
spray spectra of the peptides of Table 1 are relatively 
noise-free. The most signmcant feature of these elec- 
trospray spectra (except for LE and ME) is the pres- 
ence of a series of multiply charged molecular ions. 
The spectra also contain ions at the low mass range 
(see Figures 1 and 2) that probably stem from other 
constituents present in the solvent stream. For exam- 
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Table 2. Electrospray mass spectra of neumpeptides 
Neuropeptide 
Number of 
basic amino Relative abundance 
acid residues [M + HI+ [M + 2H12+ [M + 3HJa+ [M + 4H14+ [M + 5H16+ [M + 6Hj6+ 
LE 0 100 - - - - _ 
ME 0 100 - - - - 
ME-LVS-LYS 2 4 100 5 - - - 
Dynorphin A ,_e 2 <l 100 8 - - - 
Dynorphin A ,_e 3 <I 12 100 - - - 
Dynorphin A ,_,o 3 <l 17 100 - - - 
Dynorphin A, ,3 5 - 3 67 100 - - 
Dynorphin A j-1, 5 1 15 100 <l - 
Dynorphin E,.,9 3 - 5 100 3 - - 
/3-Endorphin,.,, 5 - - 1 29 100 26 
pie, the ions at m/z 160, 178, 220, and 256 probably 
are the solvent adducts having the structures 
[tCH,OW,l+, [W-J ,OW,H 201 +r [KH,OW, - 
CH ,COOH] +, and [(CH30J?&(CH3COOH)H20]+, 
respectively. 
Multiple-charging of the peptide results from mul- 
tiple proton&ion of the parent molecule to yield 
even-electron ions of the general nature [M + nH]“+. 
The basic amino acids such as Lys and Arg play an 
important role in multiple-charging of polypeptides 
[lo, 14, 16, 341. The influence of these basic residues 
on the electrospray spectra discussed here is also 
obvious, LE (Figure 1) and ME, which lack these basic 
residues, yield a singly protonated molecule only; in 
contrast, the peptides that contain basic amino acid 
residues produce a series of multiply charged molecu- 
lar ion species. As the M, increases from LE to BE, 
the singly charged [M + H]+ species disappear. Also, 
ion current increases concomitantly with the increase 
in the number of charges until a maximum is reached, 
and then decreases rapidly. Furthermore, except for 
dynorphin A,,, and dynorphin A,_,, a proportional- 
ity exists between the number of charges of the most 
abundant ion among those clusters and the number of 
basic amino acid units present in the peptide. For 
example, for ME-Lys-Lys and dynorphin A,,, both of 
which contain two basic amino acid units, the most 
abundant ion in their electrospray mass spectra is the 
[M + 2HJ2+ ion. 
The proportionality between the number of charges 
and the number of basic amino acids is not as 
straightforward to rationalize as it appears in the 
above discussion. If that were the case, we would 
expect a one-to-one correspondence between the 
number of charges of the most abundant multiply 
charged ion and the number of the protonation sites 
(i.e., the number of basic amino acids plus the N- 
terminal site). Clearly, other factors, such as higher 
order structures, charge density, charge repulsion be- 
tween the neighboring basic amino acids, etc., play a 
role in determining the charge state of a molecule. 
The dependence of an ion’s desorption rate on droplet 
surface charge density [35], the presence of distide 
bonds in a peptide [16, 351, the voltage applied to the 
nozzle-skimmer at the entrance orifice to the mass 
spectrometer [36], and the solvents used in the elec- 
trospray process [34] also affect the charge state of a 
molecule. 
Another interesting feature of the electrospray 
spectra is the absence of any amino acid sequence- 
specific fragment ions. A significant implication of this 
deficiency, as wiU be demonstrated later for ME and 
(3E, is the potential increase in the detection sensitiv- 
Figure 2. The electrospray mitss speckum of synthetic &en- 
dorphin. The [M + 3H]‘+, [M + 4HJ’+, IM + 5HJ5+, and [M + 
6H]6+ ions appear at m/z 1156, 867, 694, and 576, respectively. 
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Table 3. Electrospray mass spechmmeS, analysis of 
methionine enkephalin in pituitary extracts 
/3E [44]), it has been difticult to analyze by FAB/MS. 
Furthermore, the M, (= 3463 Da) of @E is beyond the 
most sensitive mass range of many mass spectrome- 
ters. To circumvent these difficulties, we previously 
trypsinolyzed PE to cleave it into smaller peptide 
fragments [44, 451. The [M + HI+ ion of the tryptic 
peptide /3E,, (NAIIK) 1441 and the transition 
[NAIM + HI++ NAP [45] were monitored sepa- 
rately by FAB/MS to quantify endogenous human 
PE. The detection sensitivities of these two quantih- 
cation methods were 86 and 580 fmol DE, respec- 
tively. 
Sample 
Total Proteins Methionine 
weight (% of total enkephalin 
lg) weight) (pmol/mg protein) 
Human pituitaries 
A 0.305 15.9 9.1 
B 0.305 15.9 8.2 
C 0.353 17.6 4.7 
Canine pituitary 0.195 20.1 39.8 
Analysis of ME in individual human and canine pituifury 
extrucfs. Methionine enkephalin-like immunoreac- 
tivity was demonstrated in the human pituitary gland 
[41]. Recently, unambiguous evidence of the presence 
of ME was reported in human pituitary extracts by 
FAB and B/E linked-held scan mass spectrometry 
techniques [27]. The present electrospray mass spec- 
trometry method was applied to quantify endogenous 
ME in one whole canine and three human pituitaries. 
To determine the reproducibility of the quantitative 
method, one human pituitary was divided into two 
portions (samples A and 6). Because the other two 
human pituitaries were small, they were combined to 
provide sample C. One microgram of [2Hs-4Phe]-ME 
was added to each sample, and ME was extracted and 
purified as described above. The canine pituitary was 
also analyzed in a similar fashion. 
Table 3 contains the data from the electrospray 
mass spectrometry analysis of ME from these pitu- 
itary extracts. An electrospray mass spectrum of the 
solvent blank was also obtained between each sample 
to ensure that no carryover occurred from the previ- 
ous sample. A typical example demonstrating the 
signal-to-noise level of the analysis of a biological 
sample (sample 6) is shown in Figure 3b. The three 
human pituitary samples A, B, and C contained 9.1, 
8.2, and 4.7 pmol ME/mg protein, respectively. The 
corresponding amount in one canine pituitary was 
39.8 pmol ME/mg protein. The variation (ca. & 5%) in 
the amounts of ME determined in the two samples A 
and B of the same pituitary reflects the good repro- 
ducibility of the overall experimental steps of this 
quantification procedure. 
Quantification of P-Endorphin 
&Endorphin is an opioid-active peptide consisting of 
31 amino acids, and is derived metabolically from its 
large precursor, pro-opiomelanocortin [42]. Although 
several other forms of BE exist endogenously (e.g., 
acetyl-BE, ace@- and non-acetyl+E fragments l-26 
and l-27), opioid activity is attributable to ,BE,,,. 
Therefore, a clear understanding of the physiological 
functions of PE demands a precise and accurate 
knowledge of its distribution in body tissues and 
fluids. 
Because of the hydrophilic character of @E, as mea- 
sured by the Bull and Breese index [43] ( = +930 for 
Another feasible approach to quantifying BE is to 
monitor multiply charged molecular ions. The ion 
current due to the [M t 2H12+ ion of /3E was recorded 
by Voyksner and Pack [46] using thermospray mass 
spectrometry and by us using FAB/MS [45]. These 
two methods were capable of quantifying /?E down to 
10 and 3 pmol, respectively. 
As discussed above and shown in Figure 2, electro- 
spraying BE generates several different multiply 
charged species of intact BE. An ion bearing five 
positive charges (M /z 694) is the most dominant of 
these multiply charged species. This abundant ion is 
the logical choice to quantify endogenous /3E. For 
these measurements, the electrospray spectrum was 
acquired in the narrow mass range (again to show 
absence of interference) encompassing the [M + 
5H]“+ ion. An external calibration curve (not shown; 
linear correlation coefficient = 0.999) in the concentra- 
tion range of 5 fmol-50 pmol was obtained by plotting 
the ion current due to the [M + 5H15+ ion versus the 
amount of OE. The detection sensitivity of the present 
method is ca. 5 fmol of synthetic PE. Thus, the 
present method is approximately 17 times more sensi- 
tive than our previously reported FAB/MS method 
[44] and also does not require the trypsinolysis step. 
The electrospray mass spectrometry analysis (see in- 
set of Figure 4) of the /3E fraction indicated 660 fmol 
PE/mg protein. 
Full-Scan Electrospray Mass Spectra of Pituitary 
Extract 
A biological sample is always complex in nature and 
may contain different impurities, even after several 
chromatographic steps [27]. The chemical noise due to 
these impurities and the liquid matrix is a limiting 
factor in the FAB/MS analysis of peptides. Although 
we were able to obtain a good electrospray mass 
spectrometry signal for the [M + H]+ ion of ME in 
the pituitary extract of sample B (Figure 3b) when a 
narrow mass range was used for data acquisition, it 
was also important to determine the electrospray mass 
spectrometry response of ME compared to the solvent 
and biological impurities. The full-scan positive ion 
electrospray mass spectra in the mass range 200-1000 
u of the ME RP-I-IPLC fractions of the two separate 
pituitary samples B and C are illustrated in Figure 5. 
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Figure 4. A full-scan electrospray mass spectrum of the RF’- 
HPLC PE fraction of a human pituitary extract. The multiply 
charged molecular ions corresponding to the addition of 6, 5, 4. 
and 3 protons are seen at m/z 578, 694, 867, and 1156, respec- 
tively. The inset shows the electrospray mass spectrometry 
an+.is of endogenous &endorphin in a human pituitary ex- 
tract. 
Both spectra exhibit low background noise compared 
to FAB/MS, and display strong signals due to the 
[M+H]+ ions of ME and 12H,-4Phe]-ME, with a 
signal-to-noise ratio greater than 3 : 1 for the [M + H] + 
ion of ME. These spectra were acquired with one-tenth 
(equivalent to ca. 40 and 30 pmol ME, respectively) of 
the original.amount of ME present in those samples. 
The amount of [2H5-4Phe]-ME present in these two 
samples was ca. 170 pmol. 
We also obtained the full-scan electrospray mass 
spectrum of the PE fraction from the gradient RP- 
HPLC step. That mass spectrum (shown in Figure 4) 
is characterized by the presence of a large number of 
non-BE ions. No difficulty, however, was encoun- 
tered in identifying /3E in that mass spectrum. The 
multiply charged molecular ions characteristic of /3E, 
corresponding to the addition of 6, 5, 4, and 3 pro- 
tons, were clearly distinguishable in that spectrum at 
m/z 578, 694, 867, and 1156, respectively. It is signif- 
icant to note that FAB analysis of a similar pituitary 
sample failed to produce any ion related to BE. 
Conclusions 
The data presented in this article demonstrate the 
utility of electrospray mass spectrometry in character- 
izing and quantifying opioid peptides extracted from 
Figure 5. Full-scan electrospray mass spectra of two human 
pituitary samples (B and C). 
a biological matrix. Highlights of the technique are 
low background noise and formation of abundant 
multiply charged molecular species. The advantage of 
electrospray is that an instrument with a limited mass 
range can be used effectively to quantify even large 
peptides, as demonstrated here in the case of human 
PE. Although the multiply charged molecular ions are 
characteristic of an analyte, they do not provide any 
amino acid sequence information of the target pep- 
tide. Only MS/MS can furnish unambiguous se- 
quence-specific information from a selected molecular 
ion 126, 27, 39, 401. Our future plans to quantify ME 
and bE include the use of electrospray in combination 
with selected reaction monitoring and collision- 
activated dissociation to monitor a sequence-specific 
ion formed in a field-free region. 
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